CA 11-19 as a tumor marker for the diagnosis of colorectal cancer.

Authors

null

Bergein F Overholt

Gastrointestinal Associates, Knoxville, TN

Bergein F Overholt , Tommye Jordan , Donald J Wheeler , Herbert A. Fritsche

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3555)

DOI

10.1200/jco.2014.32.15_suppl.3555

Abstract #

3555

Poster Bd #

18

Abstract Disclosures

Similar Posters

Poster

2016 Gastrointestinal Cancers Symposium

Tumor marker CA 11-19 as a new serum blood test for monitoring colorectal cancer.

Tumor marker CA 11-19 as a new serum blood test for monitoring colorectal cancer.

First Author: John J. Costanzi

Poster

2021 ASCO Annual Meeting

Validation of a high performing blood test for multiple major cancer screenings.

Validation of a high performing blood test for multiple major cancer screenings.

First Author: Linhao Xu

Poster

2014 Gastrointestinal Cancers Symposium

Prognostic role of microRNA-34a expression in colorectal cancer.

Prognostic role of microRNA-34a expression in colorectal cancer.

First Author: Albert Y. Lin